Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.
about
P1343
Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.The genetic basis and cell of origin of mixed phenotype acute leukaemia
P2860
Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@en
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@nl
type
label
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@en
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@nl
prefLabel
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@en
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@nl
P2093
P2860
P1476
Establishment and genetic char ...... line with EP300-ZNF384 fusion.
@en
P2093
Changgeng Ruan
Haiping Dai
Huiying Qiu
Roderick A F MacLeod
Stefan Ehrentraut
Suning Chen
P2860
P2888
P356
10.1186/S13045-015-0197-2
P4510
P577
2015-08-21T00:00:00Z
P5875
P6179
1019054049